Use of an active surveillance system by the FDA to observe patterns of quinine sulfate use and adverse hematologic outcomes in CMS Medicare data
2014 · Pharmacoepidemiology and Drug Safety · 16 citations
https://doi.org/10.1002/pds.3644
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
11
Papers
1.1K
Citations
10
h-index
10
i10-index
Monika Houstoun is an academic researcher from United States Food and Drug Administration. The author has contributed to research in topics: Atrial Fibrillation Management and Outcomes & Diabetes Treatment and Management & Health Systems, Economic Evaluations, Quality of Life. The author has an h-index of 10, co-authored 10 publications.
Click to start Chat